Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Aveanna Healthcare
AVAH
$2.04B
| $3.3M | ﹤0.01% |
+266,883
| New | +$3.17M |
|
|
KBAL
2552
DELISTED
Kimball International
KBAL
| $3.29M | ﹤0.01% |
250,154
-1,862
| -0.7% | -$25.4K |
|
2553
REX American Resources
REX
$1.42B
| $3.28M | ﹤0.01% |
218,028
-654
| -0.3% | -$9.51K |
|
2554
Oppenheimer Holdings
OPY
$1.14B
| $3.28M | ﹤0.01% |
64,429
-446
| -0.7% | -$21.5K |
|
2555
Celldex Therapeutics
CLDX
$2.99B
| $3.27M | ﹤0.01% |
97,625
+83,116
| +573% | +$2.28M |
|
2556
ARKO Corp
ARKO
$896M
| $3.23M | ﹤0.01% |
351,617
+46,570
| +15% | +$474K |
|
2557
CytomX Therapeutics
CTMX
$675M
| $3.23M | ﹤0.01% |
509,929
+16,420
| +3% | +$128K |
|
2558
Bristow Group
VTOL
$1.34B
| $3.22M | ﹤0.01% |
125,725
+5,111
| +4% | +$138K |
|
|
HTB
2559
HomeTrust Bancshares
HTB
$860M
| $3.22M | ﹤0.01% |
115,321
+6,722
| +6% | +$184K |
|
|
TBRG
2560
DELISTED
TruBridge
TBRG
| $3.21M | ﹤0.01% |
96,735
+9,360
| +11% | +$297K |
|
2561
iShares MSCI EAFE ETF
EFA
$78B
| $3.21M | ﹤0.01% |
40,651
+1,595
| +4% | +$127K |
|
|
AFMD
2562
DELISTED
Affimed
AFMD
| $3.19M | ﹤0.01% |
37,564
+725
| +2% | +$66.1K |
|
|
TCRR
2563
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $3.19M | ﹤0.01% |
194,571
+6,555
| +3% | +$132K |
|
2564
Dyne Therapeutics
DYN
$4.7B
| $3.19M | ﹤0.01% |
151,626
+29,134
| +24% | +$548K |
|
|
POSH
2565
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $3.19M | ﹤0.01% |
66,763
+36,337
| +119% | +$1.56M |
|
2566
Relmada Therapeutics
RLMD
$557M
| $3.17M | ﹤0.01% |
99,167
+4,605
| +5% | +$160K |
|
2567
Annexon
ANNX
$834M
| $3.17M | ﹤0.01% |
140,865
+11,946
| +9% | +$265K |
|
2568
eGain
EGAN
$187M
| $3.17M | ﹤0.01% |
275,765
-2,888
| -1% | -$29.5K |
|
|
PRVB
2569
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $3.16M | ﹤0.01% |
374,954
+10,925
| +3% | +$88.1K |
|
|
BRY
2570
DELISTED
Berry Corp
BRY
| $3.15M | ﹤0.01% |
468,827
+2,876
| +0.6% | +$18.2K |
|
2571
Digimarc Corp
DMRC
$147M
| $3.15M | ﹤0.01% |
94,037
+2,621
| +3% | +$86.4K |
|
|
OLP
2572
One Liberty Properties
OLP
$530M
| $3.15M | ﹤0.01% |
110,951
-8,890
| -7% | -$230K |
|
2573
Napco Security Technologies
NSSC
$1.32B
| $3.15M | ﹤0.01% |
173,008
+3,044
| +2% | +$52.2K |
|
|
GATO
2574
DELISTED
Gatos Silver, Inc.
GATO
| $3.14M | ﹤0.01% |
179,449
+22,393
| +14% | +$316K |
|
|
HCCI
2575
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $3.14M | ﹤0.01% |
105,664
-846
| -0.8% | -$25.1K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.